IP Library Granted Patent US 11,718,864
Granted Patent B2
US 11,718,864 · App. 16/917,099 · Granted Aug 8, 2023

Cells and method of cell culture

Inventors: Gregory Walter Hiller (Wakefield, MA); Jeffrey Joseph Mitchell (Nashua, NH); Bhanu Chandra Mulukutla (Lawrence, MA); Pamela Mary Pegman (Weston, MA)
Assignee: Pfizer Inc.
C12P7/62C07K16/00C12P7/40C12P7/42C12P7/52C12P7/56C12P17/182C12N2500/32C12N2500/34C12N2510/00C12N2510/02C12N2511/00
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,718,864
App. No.
16/917,099
Granted
Aug 8, 2023
Kind
B2
Abstract

The invention relates to a method of cell culture where the cells are modified to reduce the level of synthesis of growth and/or productivity inhibitors by the cell. The invention also relates to a method of cell culture for improving cell growth and productivity, in particular in fed-batch culture of mammalian cells at high cell density. The invention further relates to a method of producing cells with improved cell growth and/or productivity in cell culture and to cells obtained or obtainable by such methods.

Claims (13)

1. A cell comprising two or more exogenous wild-type genes selected from the group consisting of Pah, PCBD1, Hpd, and Hgd, wherein expression of said two or more exogenous wild-type genes reduces the level of synthesis of growth and/or productivity inhibitors produced by the cell when compared to a cell that does not comprise said two or more exogenous wild-type genes.

2. The cell according to claim 1 , wherein the cell comprises a combination of constructs selected from the group consisting of:

(i) an expressible nucleic acid or vector construct comprising a PCDB1 gene,

(ii) an expressible nucleic acid or vector construct comprising a Pah gene,

(iii) an expressible nucleic acid or vector construct comprising a Pah gene and PCDB1 gene,

(iv) an expressible nucleic acid or vector construct comprising a Hpd gene, and

(v) an expressible nucleic acid or vector construct comprising a Hgd gene.

3. The cell of claim 1 , wherein the cell comprises the exogenous wild-type genes Pah and PCBD1.

4. The cell of claim 3 , wherein the cell further comprises an exogenous wild-type gene of at least one of Hpd or Hgd.

5. The cell of claim 3 , wherein the cell is a Chinese hamster ovary (CHO) cell or a human embryonic kidney cell (HEK)

6. The cell of claim 1 , wherein the cell comprises the four exogenous wild-type genes Pah, PCBD1, Hpd, and Hgd.

7. The cell of claim 1 , wherein the cell is a Chinese hamster ovary (CHO) cell.

8. The cell of claim 1 , wherein the cell is a human embryonic kidney cell (HEK).

Assignments (1)
ASSIGNEE ADDRESS CORRECTION Recorded Mar 20, 2023
From: PFIZER INC.
To: PFIZER INC.
Reel/Frame 063119/0087 →